ContraFect Announces Expanded Research Collaboration with The Rockefeller University to Identify Lysin Therapeutics Targeting Gram-negative Bacteria November 14, 2016
ContraFect Reports Third Quarter 2016 Financial Results and Provides Business Update November 9, 2016
ContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency August 4, 2016
